Financials Corteva, Inc.

Equities

CTVA

US22052L1044

Agricultural Chemicals

Market Closed - Nyse 04:00:02 2024-04-26 pm EDT 5-day change 1st Jan Change
54.92 USD +0.40% Intraday chart for Corteva, Inc. +0.22% +14.61%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 22,123 28,847 34,463 41,998 33,771 38,383 - -
Enterprise Value (EV) 1 20,476 26,157 31,121 40,114 33,616 37,874 37,357 36,911
P/E ratio -23.1 x 42.5 x 19.9 x 35.4 x 46.5 x 27.1 x 20.8 x 16.9 x
Yield 1.32% 1.34% 1.14% 0.99% - 1.22% 1.32% 1.44%
Capitalization / Revenue 1.6 x 2.03 x 2.2 x 2.41 x 1.96 x 2.18 x 2.09 x 2.02 x
EV / Revenue 1.48 x 1.84 x 1.99 x 2.3 x 1.95 x 2.15 x 2.03 x 1.94 x
EV / EBITDA 10.3 x 12.5 x 12.1 x 12.4 x 9.94 x 10.6 x 9.27 x 8.55 x
EV / FCF -220 x 16.5 x 14.4 x 150 x 21.2 x 20.2 x 17.9 x 16.4 x
FCF Yield -0.45% 6.07% 6.92% 0.67% 4.72% 4.95% 5.58% 6.09%
Price to Book 0.91 x 1.16 x 1.35 x 1.66 x 1.36 x 1.51 x 1.45 x 1.41 x
Nbr of stocks (in thousands) 748,401 745,016 728,909 714,492 704,729 698,880 - -
Reference price 2 29.56 38.72 47.28 58.78 47.92 54.92 54.92 54.92
Announcement Date 1/30/20 2/3/21 2/2/22 2/1/23 1/31/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 13,846 14,217 15,655 17,455 17,226 17,585 18,360 19,006
EBITDA 1 1,987 2,087 2,576 3,224 3,381 3,584 4,030 4,318
EBIT 1 987 910 2,055 2,001 2,170 2,410 2,755 3,052
Operating Margin 7.13% 6.4% 13.13% 11.46% 12.6% 13.7% 15% 16.06%
Earnings before Tax (EBT) 1 -316 675 2,346 1,426 1,093 1,967 2,490 2,586
Net income 1 -959 681 1,759 1,147 735 1,414 1,812 1,993
Net margin -6.93% 4.79% 11.24% 6.57% 4.27% 8.04% 9.87% 10.49%
EPS 2 -1.280 0.9100 2.370 1.660 1.030 2.030 2.646 3.248
Free Cash Flow 1 -93 1,589 2,154 267 1,586 1,874 2,085 2,249
FCF margin -0.67% 11.18% 13.76% 1.53% 9.21% 10.66% 11.35% 11.83%
FCF Conversion (EBITDA) - 76.14% 83.62% 8.28% 46.91% 52.29% 51.73% 52.09%
FCF Conversion (Net income) - 233.33% 122.46% 23.28% 215.78% 132.51% 115.06% 112.84%
Dividend per Share 2 0.3900 0.5200 0.5400 0.5800 - 0.6705 0.7276 0.7912
Announcement Date 1/30/20 2/3/21 2/2/22 2/1/23 1/31/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 2,400 3,479 4,601 6,252 2,780 3,825 4,884 6,045 2,590 3,707 4,632 6,274 2,741 3,925 4,979
EBITDA 1 -51 262 1,039 1,719 96 370 1,231 1,746 18 386 1,011 1,909 140.8 523.4 1,284
EBIT 1 -336 124 732 1,417 -36 66 944 1,440 -114 74 810.7 1,509 -193.7 198.3 -
Operating Margin -14% 3.56% 15.91% 22.66% -1.29% 1.73% 19.33% 23.82% -4.4% 2% 17.5% 24.05% -7.07% 5.05% -
Earnings before Tax (EBT) 1 8 245 698 1,327 -396 -203 776 1,084 -444 -323 654.1 1,418 -240.6 45.9 -
Net income 1 30 159 564 969 -331 -55 595 714 -321 -253 485.2 1,067 -213.4 42.44 -
Net margin 1.25% 4.57% 12.26% 15.5% -11.91% -1.44% 12.18% 11.81% -12.39% -6.82% 10.48% 17.01% -7.79% 1.08% -
EPS 2 0.0500 0.2200 0.7800 1.330 -0.4500 -0.0600 0.8300 1.000 -0.4500 -0.3600 0.6632 1.507 -0.3274 0.0490 -
Dividend per Share 2 0.1400 0.1400 0.1400 0.1500 0.1500 0.1500 0.1500 0.1600 0.1600 - 0.1650 0.1640 0.1705 0.1734 0.1786
Announcement Date 11/3/21 2/2/22 5/4/22 8/4/22 11/3/22 2/1/23 5/3/23 8/3/23 10/27/23 1/31/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 1,647 2,690 3,342 1,884 155 508 1,025 1,472
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -93 1,589 2,154 267 1,586 1,874 2,085 2,249
ROE (net income / shareholders' equity) 2.17% 2.77% 7.01% 7.63% 7.6% 7.66% 9.06% 9.88%
ROA (Net income/ Total Assets) 1.42% 1.6% 4.14% 4.55% 4.47% 4.19% 4.81% 5.19%
Assets 1 -67,516 42,523 42,496 25,194 16,438 33,746 37,632 38,427
Book Value Per Share 2 32.50 33.40 34.90 35.50 35.20 36.40 37.80 39.10
Cash Flow per Share 2 1.430 2.750 3.680 1.200 2.510 3.440 3.970 4.270
Capex 1 1,163 475 573 605 595 625 648 650
Capex / Sales 8.4% 3.34% 3.66% 3.47% 3.45% 3.55% 3.53% 3.42%
Announcement Date 1/30/20 2/3/21 2/2/22 2/1/23 1/31/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
54.92 USD
Average target price
62.45 USD
Spread / Average Target
+13.71%
Consensus
  1. Stock Market
  2. Equities
  3. CTVA Stock
  4. Financials Corteva, Inc.